By Bhanvi Satija and Puyaan Singh (Reuters) - The U.S. Food and Drug Administration on Tuesday declined full approval for ...

Ursodeoxycholic acid (UDCA) is widely used for the treatment of chronic cholestatic liver diseases. However, a recent randomized, controlled trial has surprisingly shown that the use of high-dose ...

10月14日晚间，葵花药业发布公告称，公司控股子公司葵花药业集团(唐山)生物制药有限公司于近日收到国家药品监督管理局下发的关于熊去氧胆酸胶囊申请注册上市许可的《受理通知书》。

Get detailed information on Ursodeoxycholic Acid, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new ...

Discover all the brand names or Trade names of generic drug called Ursodeoxycholic Acid. This serves as a crucial reference for healthcare professionals, patients, caregivers, and anyone looking ...

Ipsen announced today that the National Institute for Health and Care Excellence (NICE) has recommended elafibranor 80mg ...

The FDA informed Intercept that it is unable to approve the sNDA in its current form, consistent with the outcome of the Gastrointestinal Drugs Advisory Committee (GIDAC) meeting in September 2024. In ...

He is bullish on the recent progress of the company's portfolio, including the FDA granting accelerated approval for Livdelzi in combination with ursodeoxycholic acid for the treatment of primary ...

Age at presentation, menopausal status, pregnancy, histological cirrhosis, duration of illness, autoantibody profile, and comorbid conditions, such as osteoporosis or diabetes, do not alter the ...

Investors' focus is likely to be on GILD???s HIV franchise performance and oncology sales when the company reports ...